New Horizon Health Announced 2022 Interim Report: Revenue Up 414% YoY, Gross Margin Climbs to 82% BioTech August 19, 2022 New Horizon Health (HKG : 6606), China’s leading biotechnology company for early cancer screening, announced its half-year results for the…
